| Issue |
Med Sci (Paris)
Volume 33, Number 4, Avril 2017
|
|
|---|---|---|
| Page(s) | 373 - 375 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20173304002 | |
| Published online | 12 May 2017 | |
Akkermansia muciniphila, une bactérie pour lutter contre le syndrome métabolique
Optimisation des effets bénéfiques et évaluation de la sûreté chez l’homme
Optimization and safety assessment of Akkermansia muciniphila for human administration
Université catholique de Louvain, Louvain drug research institute LDRI, WELBIO (Walloon excellence in lifesciences and biotechnology), groupe de recherche en métabolisme et nutrition, avenue E. Mounier, 73 B1.73.11, B-1200 Bruxelles, Belgique
Cet article ne possède pas de résumé.
© 2017 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
